Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.60
-0.07 (-0.18%)
At close: May 6, 2026, 4:00 PM EDT
40.46
+0.85 (2.16%)
After-hours: May 6, 2026, 7:26 PM EDT
Centessa Pharmaceuticals Revenue
In the year 2025, Centessa Pharmaceuticals had annual revenue of $15.00M.
Revenue (ttm)
$15.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
118
Market Cap
6.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCNTA News
- 5 weeks ago - Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewsWire
- 5 weeks ago - Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs - Invezz
- 5 weeks ago - Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs - CNBC
- 5 weeks ago - Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion - WSJ
- 5 weeks ago - Eli Lilly to buy Centessa Pharma in $6.3 billion deal - Reuters
- 5 weeks ago - Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PRNewsWire
- 2 months ago - Centessa Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire